1. Home
  2. CET vs ARDX Comparison

CET vs ARDX Comparison

Compare CET & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CET

Central Securities Corporation

HOLD

Current Price

$50.40

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CET
ARDX
Founded
1929
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CET
ARDX
Price
$50.40
$5.70
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$15.14
AVG Volume (30 Days)
36.2K
3.5M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
5.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
N/A
$38.22
Revenue Next Year
N/A
$33.85
P/E Ratio
$6.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.24
$3.50
52 Week High
$52.95
$8.40

Technical Indicators

Market Signals
Indicator
CET
ARDX
Relative Strength Index (RSI) 37.29 36.62
Support Level $49.88 $5.49
Resistance Level $51.02 $6.23
Average True Range (ATR) 0.88 0.26
MACD -0.16 -0.04
Stochastic Oscillator 11.85 9.41

Price Performance

Historical Comparison
CET
ARDX

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: